The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy
Open accessAbstract
OBJECTIVE: To evaluate mechanisms underlying diabetic neuropathy progression using indexes of sural nerve morphometry obtained from two identical randomized, placebo-controlled clinical trials. RESEARCH DESIGN AND METHODS: Sural nerve myelinated fiber density (MFD), nerve conduction velocities (NCVs), vibration perception thresholds, clinical symptom scores, and a visual analog scale for pain were analyzed in participants with diabetic neuropathy. A loss of ≥500 fibers/mm2 in sural nerve MFD over 52 weeks was defined as progressing diabetic neuropathy, and a MFD loss of ≤100 fibers/mm2 during the same time interval as nonprogressing diabetic neuropathy. The progressing and nonprogressing cohorts were matched for baseline characteristics using an O'Brien rank-sum and baseline MFD. RESULTS: At 52 weeks, the progressing cohort demonstrated a 25% decrease (P < 0.0001) from baseline in MFD, while the nonprogressing cohort remained unchanged. MFD was not affected by active drug treatment (P = 0.87), diabetes duration (P = 0.48), age (P = 0.11), or BMI (P = 0.30). Among all variables tested, elevated triglycerides and decreased peroneal motor NCV at baseline significantly correlated with loss of MFD at 52 weeks (P = 0.04). CONCLUSIONS: In this cohort of participants with mild to moderate diabetic neuropathy, elevated triglycerides correlated with MFD loss independent of disease duration, age, diabetes control, or other variables. These data support the evolving concept that hyperlipidemia is instrumental in the progression of diabetic neuropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other
Mann, H. B., & Whitney, D. R. (1947) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177730491 · Cited by 14,320
Missing Value Estimation Methods for DNA Microarrays
Troyanskaya, O., Cantor, M., Sherlock, G., Brown, P., Hastie, T., Tibshirani, R., Botstein, D., & Altman, R. B. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.6.520 · Cited by 4,230
Clinical Methods: The History, Physical, and Laboratory Examinations
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-7-563_2 · Cited by 1,396
Vascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Clinical Practice Recommendations
Fowler, M. J. (2011) · Clinical Diabetes · doi:10.2337/diaclin.29.4.163 · Cited by 995
Diabetic neuropathy: Mechanisms to management
Edwards, J. L., Vincent, A. M., Cheng, H. T., & Feldman, E. L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.005 · Cited by 790
Self-citationOrange: From Experimental Machine Learning to Interactive Data Mining
Demšar, J., Zupan, B., Leban, G., & Curk, T. (2004) · Lecture Notes in Computer Science · doi:10.1007/978-3-540-30116-5_58 · Cited by 426
Algorithmic Stability and Sanity-Check Bounds for Leave-One-Out Cross-Validation
Kearns, M., & Ron, D. (1999) · Neural Computation · doi:10.1162/089976699300016304 · Cited by 407
Dyck, P. J., Davies, J. L., Litchy, W. J., & O'Brien, P. C. (1997) · Neurology · doi:10.1212/wnl.49.1.229 · Cited by 382
Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy
Greene, D. A., Arezzo, J. C., Brown, M. B., & the Zenarestat Study Group (1999) · Neurology · doi:10.1212/wnl.53.3.580 · Cited by 278
Guidelines for Computer Modeling of Diabetes and Its Complications
American Diabetes Association Consensus Panel (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2262 · Cited by 270
Sima, A. A. F., Calvani, M., Mehra, M., Amato, A., & for the Acetyl-l-Carnitine Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.1.89 · Cited by 234
Self-citationIMPROVEMENT IN NERVE CONDUCTION FOLLOWING TREATMENT IN NEWLY DIAGNOSED DIABETICS
Ward, J. D., Fisher, D. J., Barnes, C. G., Jessop, J. D., & Baker, R. W. R. (1971) · The Lancet · doi:10.1016/s0140-6736(71)92415-9 · Cited by 234
The DCCT Research Group (1988) · Diabetes · doi:10.2337/diab.37.4.476 · Cited by 229
Chaturvedi, N., Sjoelie, A.-K., Porta, M., Aldington, S. J., Fuller, J. H., Songini, M., & Kohner, E. M. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.284 · Cited by 209
Kempler, P., Tesfaye, S., Chaturvedi, N., Stevens, L. K., Webb, D. J., Eaton, S., Kerényi, Z., Tamás, G., Ward, J. D., Fuller, J. H., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00821.x · Cited by 203
Davis, T. M. E., Yeap, B. B., Davis, W. A., & Bruce, D. G. (2008) · Diabetologia · doi:10.1007/s00125-007-0919-2 · Cited by 200
Oxidative stress and endothelial dysfunction in vascular disease
Pennathur, S., & Heinecke, J. W. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0041-3 · Cited by 185
Tsuzura, S., Ikeda, Y., Suehiro, T., Ota, K., Osaki, F., Arii, K., Kumon, Y., & Hashimoto, K. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.009 · Cited by 119
Gaddis, G., & Gaddis, M. L. (1990) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)82571-5 · Cited by 115
Skin biopsy: a new tool for diagnosing peripheral neuropathy
Lauria, G., & Lombardi, R. (2007) · BMJ · doi:10.1136/bmj.39192.488125.be · Cited by 112
Remote neurotrophic support of epidermal nerve fibres in experimental diabetes
Toth, C. C., Brussee, V., & Zochodne, D. W. (2006) · Diabetologia · doi:10.1007/s00125-006-0169-8 · Cited by 106
Diabetic Neuropathy Differs in Type 1 and Type 2 Diabetes
Sima, A. A. F., & Kamiya, H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.004 · Cited by 105
Self-citationVeves, A., Malik, R. A., Lye, R. H., Masson, E. A., Sharma, A., Schady, W., & Boulton, A. J. M. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb01530.x · Cited by 103
Rescue and regeneration of injured peripheral nerve axons by intrathecal insulin
Toth, C. C., Brussee, V., Martinez, J. A., McDonald, D. S., Cunningham, F. A., & Zochodne, D. W. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.11.065 · Cited by 101
Letter: Treatment of inoperable carcinoma of bronchus.
Laing, A. H., Berry, R. J., Newman, C. R., & Peto, J. (1976) · PubMed · doi:10.1016/s0140-6736(76)90268-3 · Cited by 92
Increased Transcapillary Escape Rate of Albumin in Microalbuminuric Type II Diabetic Patients
Nannipieri, M., Rlzzo, L., Rapuano, A., PILO, A., Penno, G., & Navalesi, R. (1995) · Diabetes Care · doi:10.2337/diacare.18.1.1 · Cited by 88
Lipid modulation in insulin-dependent diabetes mellitus
Fried, L. F., Forrest, K. Y. Z., Ellis, D., Chang, Y., Silvers, N., & Orchard, T. J. (2001) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00140-4 · Cited by 84
Neuropathology: The Diagnostic Approach
Kim, J. H. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199808000-00016 · Cited by 71
Russell, J. W., Karnes, J. L., & Dyck, P. J. B. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00243-u · Cited by 62
Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy
Vinik, A. I., Bril, V., Litchy, W. J., Price, K. L., Bastyr, E. J., & MBBQ STUDY GROUP (2005) · Muscle & Nerve · doi:10.1002/mus.20423 · Cited by 59
A rank‐based sample size method for multiple outcomes in clinical trials
Huang, P., Woolson, R. F., & O’Brien, P. C. (2008) · Statistics in Medicine · doi:10.1002/sim.3182 · Cited by 49
SAINI, A., Arun, K., Kaul, C. L., & SHARMA, S. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2004.04.004 · Cited by 31
Risk factors for hospitalization due to diabetes complications
Tomlin, A. M., Dovey, S. M., & Tilyard, M. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.12.017 · Cited by 31
Lipid‐lowering therapy in patients with type 2 diabetes: the case for early intervention
Steinmetz, A. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.806 · Cited by 20
American Diabetes Association: clinical practice recommendations 1995.
(1995) · PubMed · Cited by 20
A milestone in diabetes management
Chisholm, D. J. (1993) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb141332.x · Cited by 17
Cited by
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Diabetic neuropathy: clinical manifestations and current treatments
Callaghan, B. C., Cheng, H. T., Stables, C. L., Smith, A. L., & Feldman, E. L. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70065-0 · Cited by 1,211
Self-citationEpidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes
Hicks, C. W., & Selvin, E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1212-8 · Cited by 798
Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy
Tesfaye, S., & Selvarajah, D. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2239 · Cited by 615
Diabetic neuropathy: cellular mechanisms as therapeutic targets
Vincent, A. M., Callaghan, B. C., Smith, A. L., & Feldman, E. L. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.137 · Cited by 566
Self-citation
Metadata
- Authors
- Wiggin, T. D., Sullivan, K. A., Pop-Busui, R., Amato, A., Sima, A. A. F., & Feldman, E. L.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-05-01
- Volume
- 58
- Issue
- 7
- Pages
- 1634-1640
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2127944534
- Cited by
- 344
- References
- 38
- FWCI
- 11.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.